CIPLA
-
Coronavirus: Moderna vaccine gets approval for restricted emergency use in India
Scroll Staff
-
Coronavirus: India eases norms for clearing foreign-made vaccines, Pfizer, Cipla likely to benefit
Scroll Staff
-
Coronavirus: Cipla, Roche launch antibody cocktail in India at Rs 59,750 per dose
Scroll Staff
-
Coronavirus: Maharashtra, Delhi in list of five states to get first set of remdesivir drug
Scroll Staff
-
New Year smiles: As firecrackers burst at Priyanka Chopra wedding, social media saw hypocrisy shine
Anirudh A Ashar
-
To reduce impact of GST on medicines, NPPA notifies new prices for 761 drugs
Scroll Staff
-
In the news: New ‘test and treat’ HIV policy, Cipla vs the pharma pricing regulator and more
Scroll Staff
-
Centre sources out-of-stock HIV drug through global agency, starts paying Cipla its dues: The Hindu
Scroll Staff
-
An HIV medicine for toddlers is out of stock across India
Menaka Rao
-
637 HIV+ people write to Centre asking it to pay Cipla for life-saving drug
Scroll Staff
-
Is 74% foreign direct investment in brownfield pharma really bad for Indian generics?
Prashant Reddy
-
The new pharma FDI policy undermines Indian generics, which may make drugs more expensive
Leena Menghaney
-
Scroll.in stories you may have missed this week
Scroll Staff
-
How the romance between an Aligarh Muslim and a Lithuanian Jew has shaped an Indian pharma major
Kenneth X. Robbins and John Mcleod